Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
9.50
Dollar change
-0.05
Percentage change
-0.52
%
IndexRUT P/E- EPS (ttm)-2.25 Insider Own1.69% Shs Outstand23.82M Perf Week-2.16%
Market Cap225.09M Forward P/E- EPS next Y-1.53 Insider Trans0.00% Shs Float23.42M Perf Month-0.73%
Income-52.69M PEG- EPS next Q-0.61 Inst Own85.63% Short Float3.18% Perf Quarter-16.15%
Sales331.52M P/S0.68 EPS this Y61.14% Inst Trans-7.12% Short Ratio3.84 Perf Half Y9.95%
Book/sh7.78 P/B1.22 EPS next Y10.77% ROA-16.21% Short Interest0.74M Perf Year90.38%
Cash/sh5.24 P/C1.81 EPS next 5Y- ROE-25.33% 52W Range4.93 - 13.33 Perf YTD73.04%
Dividend Est.- P/FCF- EPS past 5Y- ROI-25.98% 52W High-28.73% Beta1.03
Dividend TTM- Quick Ratio2.34 Sales past 5Y-1.72% Gross Margin47.52% 52W Low92.50% ATR (14)0.48
Dividend Ex-Date- Current Ratio2.66 EPS Y/Y TTM60.85% Oper. Margin-15.32% RSI (14)46.66 Volatility5.63% 5.24%
Employees834 Debt/Eq0.11 Sales Y/Y TTM1.12% Profit Margin-15.89% Recom3.00 Target Price10.00
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q87.24% Payout- Rel Volume0.84 Prev Close9.55
Sales Surprise5.58% EPS Surprise49.57% Sales Q/Q5.80% EarningsNov 07 AMC Avg Volume194.12K Price9.50
SMA20-4.03% SMA50-0.04% SMA2005.58% Trades Volume162,201 Change-0.52%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Upgrade William Blair Mkt Perform → Outperform
Aug-08-23Downgrade JP Morgan Overweight → Neutral $15 → $8
Jul-14-23Downgrade Needham Buy → Hold
Jan-17-23Downgrade William Blair Outperform → Mkt Perform
Dec-09-21Upgrade Needham Hold → Buy $47
Nov-02-21Upgrade JP Morgan Underweight → Neutral $45
Aug-05-21Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Jun-04-21Upgrade William Blair Mkt Perform → Outperform
Dec-14-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $60
Jul-23-20Downgrade Needham Buy → Hold
Nov-25-24 09:55AM
Nov-08-24 08:00PM
04:02AM
Nov-07-24 06:10PM
05:05PM
04:05PM Loading…
04:05PM
04:04PM
09:16AM
Nov-06-24 07:43AM
Nov-04-24 08:30AM
Oct-17-24 08:30AM
Oct-09-24 05:09PM
Oct-08-24 08:30AM
Sep-05-24 08:30AM
Aug-22-24 01:16PM
12:00PM Loading…
Aug-08-24 12:00PM
Aug-07-24 11:34AM
Aug-06-24 06:05PM
05:06PM
04:05PM
Jul-22-24 06:24AM
Jul-16-24 08:30AM
Jul-15-24 09:00AM
Jul-03-24 04:10PM
Jun-06-24 11:31AM
Jun-03-24 04:05PM
May-09-24 01:29PM
May-08-24 01:27PM
07:14AM
04:07AM
09:55PM Loading…
May-07-24 09:55PM
08:00PM
06:33PM
05:32PM
04:05PM
Apr-10-24 08:30AM
Mar-28-24 11:30AM
11:26AM
Mar-25-24 08:30AM
Mar-07-24 04:00PM
Feb-29-24 08:28AM
Feb-28-24 09:22AM
06:47AM
Feb-27-24 07:30PM
06:25PM
05:30PM
04:48PM
04:05PM
Feb-26-24 09:15AM
Feb-23-24 09:00AM
Feb-01-24 07:03AM
Jan-30-24 04:00PM
Jan-24-24 04:00PM
Jan-08-24 07:10AM
Jan-02-24 09:29AM
Dec-07-23 11:31AM
Nov-13-23 08:30AM
Nov-10-23 09:30AM
Nov-09-23 02:30PM
Nov-08-23 11:09AM
09:57AM
Nov-07-23 04:36PM
04:05PM
Oct-16-23 09:55AM
Oct-13-23 09:35AM
Oct-10-23 04:00PM
Oct-09-23 11:15AM
Sep-18-23 08:30AM
Sep-07-23 08:30AM
Aug-08-23 11:40AM
08:30AM
06:07AM
Aug-07-23 08:30PM
05:25PM
04:14PM
04:01PM
08:30AM
Jul-17-23 12:46PM
Jul-14-23 11:01AM
Jul-13-23 08:30AM
Jul-12-23 06:58AM
Jun-02-23 06:46PM
May-18-23 04:53PM
May-16-23 06:26AM
May-15-23 05:37PM
May-05-23 11:29AM
May-04-23 07:00PM
06:15PM
05:06PM
04:05PM
Apr-26-23 08:00PM
Apr-21-23 02:37PM
Apr-18-23 07:31AM
Apr-06-23 04:05PM
Apr-04-23 06:09PM
Mar-27-23 01:22PM
10:22AM
Mar-22-23 04:05PM
08:24AM
Mar-08-23 08:30AM
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Kevin Raymond MerrillCEO and PresidentDec 01 '24Option Exercise0.0028,333028,333Dec 03 05:08 PM
Ramade GregoireChief Commercial OfficerDec 01 '24Option Exercise0.0031,565031,565Dec 03 05:05 PM
JASON SOMEROfficerAug 09 '24Proposed Sale12.034,69056,423Aug 09 04:53 PM
Somer JasonEVP, Gen. Counsel & SecretaryJun 01 '24Option Exercise0.0057705,029Jun 04 05:08 PM
Somer JasonEVP, Gen. Counsel & SecretaryMay 10 '24Sale8.5610,00085,6004,452May 14 06:43 PM
Somer JasonEVP, Gen. Counsel & SecretaryMay 01 '24Option Exercise0.0019,276025,764May 03 06:15 PM
Glezer StanislavEVP, R&D & Chief Med. OfficerMay 01 '24Option Exercise0.0032,638048,744May 03 06:14 PM
Somer JasonEVP, Gen. Counsel & SecretaryMar 01 '24Option Exercise0.007,150011,064Mar 05 07:10 PM
Glezer StanislavEVP, R&D & Chief Med. OfficerMar 01 '24Option Exercise0.0013,914023,729Mar 05 07:08 PM